Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Cutting expenses is essential for paying off credit cards. Discover practical tips to reduce your spending and regain financial control.
20,606 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
In this morning minute, crypto markets buckled as hawkish Fed signals raised rate hike odds. We unpack the drivers, s...
The U.S. Treasury proposes a drastic sanction to cut a Swiss bank off from dollar clearing amid suspected Iran and Ru...
Amazon's MGM-backed film Project Hail Mary roared out of the gate with an $80.5 million opening in the U.S. and Canad...
In the AI inference era, memory and efficiency win more than raw compute. This sleeping semiconductor giant sits pois...
A well-known consumer stock has faced a sharp sell-off as markets wobble. This guide breaks down why the market punis...
Bitcoin flows cool $619 signals a turning point as oil prices surge and macro pressure rises. This deep dive explains...
A market dip in the chip sector created a rare buying opportunity. This guide features three thoughtful picks to own ...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
A small mortgage broker pulled off a landmark win against a mega lender in a high-stakes deal, offering a playbook fo...
Lending activity in January offered cautious optimism, but analysts say the real test comes in July as the spring mar...